ReviewRSC medicinal chemistry2025
Leveraging targeted kinase degradation as a novel therapeutic strategy for Alzheimer's disease.
Elisa Tassinari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it